PDCD1 and non-small cell lung carcinoma: As previously established, PD‐1/PD‐L1 inhibitors plus chemotherapy is not effective for all patients with advanced NSCLC; even in patients in whom this treatment is effective, a durable response is not necessarily achieved.6, 7, 20, 21